BCD-281

· Biocad

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BCD-281, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis [Phase 3]